Summit Therapeutics SMMT Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's common stock, shares, outstanding?
- Summit Therapeutics (SMMT) reported common stock, shares, outstanding of $776.02M in Q1 2026.
- How has Summit Therapeutics's common stock, shares, outstanding changed year-over-year?
- Summit Therapeutics's common stock, shares, outstanding increased by 4.6% year-over-year, from $741.61M to $776.02M.
- What is the long-term trend for Summit Therapeutics's common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Summit Therapeutics's common stock, shares, outstanding has grown at a 56.5% compound annual growth rate (CAGR), from $82.58M to $775.37M.